This is considered the standard ratio because it makes the math very straightforward
& Gasser, H
Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
Beyond its cytoskeletal effects, TB-500 forms functional complexes with PINCH (particularly interesting new cysteine-histidine-rich protein) and integrin-linked kinase (ILK), activating the survival kinase Akt while inhibiting TNF--induced NF-B activation through blocking of RelA/p65 translocation
That said, the clearest human evidence so far is a small pilot where three months of B12 brought deficient older adults strength up to match non-deficient peers promising, but larger trials are the next step, especially on whether B12 supplementation helps people who arent prone to deficiencies
